Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by Methotrexate
Open Access
- 1 April 2003
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 121 (4) , 437-440
- https://doi.org/10.1001/archopht.121.4.437
Abstract
Research from JAMA Ophthalmology — Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by MethotrexateKeywords
This publication has 6 references indexed in Scilit:
- Etanercept therapy in children with treatment-resistant uveitisArthritis & Rheumatism, 2001
- Use of methotrexate in the management of sight-threatening uveitisOcular Immunology and Inflammation, 2001
- SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR (p75) FUSION PROTEIN (ENBREL) AS A THERAPY FOR RHEUMATOID ARTHRITISRheumatic Disease Clinics of North America, 1998
- Recombinant Human Tumor Necrosis Factor Receptor (P75) Fc Fusion Protein (Tnfr: Fc) in Rheumatoid ArthritisAnnals of Pharmacotherapy, 1997
- Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion ProteinNew England Journal of Medicine, 1997
- Cytokines and uveitis, a reviewCurrent Eye Research, 1992